Company / EPS (Diluted)
ClearPoint Neuro, Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.70
FY2025
5-year range
-$0.90 / -$0.43
FY2021-FY2025
Trend
+22.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 10 years, ranging from $-4.48 in FY2016 to $-0.42 in FY2020.
Based on SEC 10-K filings.
-0.70 in FY2025.
Declined from $-0.68 to $-0.70 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 22.2% year-over-year.
- Peak eps (diluted) was recorded in FY2020.
- Lowest eps (diluted) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.71 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.70 | +22.2% |
| FY2024 | -$0.90 | -32.4% |
| FY2023 | -$0.68 | +1.4% |
| FY2022 | -$0.69 | -60.5% |
| FY2021 | -$0.43 | -2.4% |
| FY2020 | -$0.42 | +25.0% |
| FY2019 | -$0.56 | +39.8% |
| FY2018 | -$0.93 | +68.3% |
| FY2017 | -$2.93 | +34.6% |
| FY2016 | -$4.48 | -5500.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026